Alpha 2.0
Login Register
» Articles » PMID: 4334979

Binding of Vitamin D to Its Human Carrier Plasma Protein

Overview
Journal Biochem Biophys Res Commun
Publisher Elsevier
Specialty Biochemistry
Date 1972 Feb 16
PMID 4334979
Citations 8
Authors
S F Nilsson
L Ostberg
P A Peterson
Affiliations
Soon will be listed here.
Citing Articles

Model-based meta-analysis for comparing Vitamin D2 and D3 parent-metabolite pharmacokinetics.

Ocampo-Pelland A, Gastonguay M, Riggs M J Pharmacokinet Pharmacodyn. 2017; 44(4):375-388.

PMID: 28466367 DOI: 10.1007/s10928-017-9525-1.

Vitamin D3 seems more appropriate than D2 to sustain adequate levels of 25OHD: a pharmacokinetic approach.

Oliveri B, Mastaglia S, Brito G, Seijo M, Keller G, Somoza J Eur J Clin Nutr. 2015; 69(6):697-702.

PMID: 25782422 DOI: 10.1038/ejcn.2015.16.

Higher 25(OH)D2 is associated with lower 25(OH)D3 and 1,25(OH)2D3.

Swanson C, Nielson C, Shrestha S, Lee C, Barrett-Connor E, Jans I J Clin Endocrinol Metab. 2014; 99(8):2736-44.

PMID: 24828488 PMC: 4121037. DOI: 10.1210/jc.2014-1069.

Plasma appearance and disappearance of an oral dose of 25-hydroxyvitamin D2 in healthy adults.

Jones K, Schoenmakers I, Bluck L, Ding S, Prentice A Br J Nutr. 2011; 107(8):1128-37.

PMID: 21896243 PMC: 3328847. DOI: 10.1017/S0007114511004132.

Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light.

Khazai N, Judd S, Jeng L, Wolfenden L, Stecenko A, Ziegler T J Clin Endocrinol Metab. 2009; 94(6):2037-43.

PMID: 19336509 PMC: 2690417. DOI: 10.1210/jc.2008-2012.